IQVIA Holdings, Inc. - Consensus 'Buy' rating and 33.4% Upside Potential
IQVIA Holdings, Inc. - Consensus 'Buy' rating and 33.4% Upside Potential
Stay updated with breaking news from Technology Analytics Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IQVIA Holdings, Inc. - Consensus 'Buy' rating and 33.4% Upside Potential
Revenue of $3,739 million for the fourth quarter, $14,410 million for the full yearGAAP Net Income of $227 million for the fourth quarter, $1,091 million for the full yearAdjusted EBITDA of $920 million for the fourth quarter, $3,346 million for the full yearGAAP Diluted Earnings per Share of $1.20 for the fourth qu...
Ritholtz Wealth Management acquired a new position in IQVIA Holdings Inc. (NYSE:IQV – Get Rating) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,749 shares of the medical research company’s stock, valued at approximately $498,000. A number of other […]
US Bancorp DE grew its position in IQVIA Holdings Inc. (NYSE:IQV – Get Rating) by 9.2% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 19,651 shares of the medical research company’s stock after buying an additional 1,655 shares during the period. US Bancorp DE’s holdings […]
IQVIA (NYSE:IQV – Get Rating) had its price objective hoisted by equities researchers at Argus from $260.00 to $275.00 in a research report issued to clients and investors on Thursday, The Fly reports. Argus’ price objective indicates a potential upside of 15.05% from the company’s previous close. Other research analysts have also issued reports about […]